The Ministry of Health and Prevention (MoHAP), United Arab Emirates, has partnered with the World Bank Group to undertake a comprehensive study titled 'The Cost of the Most Common Diseases in the UAE'.

The study aims to develop healthcare policies by utilising precise data to strategically allocate financial resources, thereby enhancing healthcare services and improving quality of life for future generations.

The study will assess the economic impact and compute the costs linked to prevalent diseases, helping to update information needed for prioritising healthcare financing in the UAE.

It aims to target resources toward the most impactful and efficient programmes, thereby enhancing the management of health resources and formulating strategies aligned with future health sector trends both locally and globally.

The agreement was signed by Dr Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector, MoHAP, and Safaa El Tayeb El Kogali, the World Bank's Country Director for the GCC countries. 

This study will play a key role in identifying the primary cost drivers by analysing data, sharing knowledge, and conducting a thorough examination of disease costs.